LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM

Reporting ownerCIK 0001423029

Christopher Richard Anzalone

30 transactions in one company, from December 12, 2025 to January 2, 2026.

Transactions: 301 company
Bought · P: $0open market
Sold · S: $24.0Mopen market
Net: −$24.0Mnet selling

By company

Where this insider traded.

Company	Ticker	Trades	Bought	Sold
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	30	—	$24.0M

All transactions

30 in total, newest filings first.

Company	Ticker	Insider	Date	Code	Shares	Price	Value
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Jan 2	SPLAN	5,771	$66.39	$383K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Jan 2	SPLAN	7,416	$65.88	$489K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEODERIV	Dec 29	MPLAN	16,545	$0.00	—?
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEODERIV	Dec 29	MPLAN	35,181	$0.00	—?
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 29	SPLAN	16,545	$68.69	$1.1M
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 29	SPLAN	35,181	$69.33	$2.4M
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 29	MPLAN	16,545	$6.15	$102K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 29	MPLAN	35,181	$6.15	$216K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 22	SPLAN	2,574	$68.85	$177K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 22	SPLAN	10,012	$68.33	$684K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 19	SPLAN	1,319	$68.48	$90K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 19	SPLAN	8,147	$68.01	$554K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 19	SPLAN	3,979	$66.67	$265K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 17	S	1,981	$66.30	$131K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 17	S	982	$65.53	$64K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 17	S	35,750	$64.51	$2.3M
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 17	S	46,287	$63.55	$2.9M
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 16	S	3,221	$67.87	$219K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 16	S	166	$66.77	$11K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 16	S	1,300	$65.77	$86K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 16	S	1,000	$64.96	$65K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 16	S	6,661	$64.29	$428K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 16	S	8,476	$62.94	$533K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 16	S	14,095	$62.12	$876K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 16	S	10,963	$61.25	$671K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 16	S	8,416	$60.51	$509K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 15	S	8,147	$69.96	$570K
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 15	S	21,321	$69.28	$1.5M
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 15	S	100,532	$68.67	$6.9M
ARROWHEAD PHARMACEUTICALS, INC.	ARWR	Christopher Richard AnzaloneCEO	Dec 12	A	180,000	$0.00	—